|
[news 2001
- 2002]
Dec. 4, 2002: Cytochroma raises $6.5 million in third
round of Series B Financing
GO
>>
July 12,
2002: Eleven patents issued for Queen's-generated discoveries
GO
>>
June 6, 2002: PARTEQ Innovations, spinoffs highlight
leading-edge technologies at BIO 2002
GO
>>
March 25, 2002: RPP grant to further Queen's-NRC
investigations into novel nitrate drugs
GO
>>
March 18, 2002: PARTEQ spinoff GB Therapeutics announces
new board of directors
GO
>>
Feb. 7, 2002: IPM awards PARTEQ $720,000 for internship
program
GO
>>
Feb. 4, 2002: PARTEQ, Cardiomics receive KTC Awards
of Excellence
GO
>>
Dec. 20, 2001: Performance Plants announces $4.24 million
financing deal
GO
>>
Dec. 5, 2001: Cardiomics announces second-round financing
from Working Ventures-Queen's fund
GO
>>
Nov. 29, 2001: Cellegy Pharmaceuticals acquires PARTEQ
spinoff Vaxis
GO
>>
Nov. 14, 2001: PARTEQ spinoffs win Synergy Awards
GO
>>
Sept. 20, 2001: Europe approves patent for ceramic coating
process developed by PARTEQ spinoff
GO
>>
June 21, 2001: PARTEQ spinoff Molecular Mining receives
$13 m in second-round financing
GO
>>
June 21, 2001: PARTEQ-licensed erectile dysfunction
drug Uprima™ receives approval for sale in Europe.
GO
>>
March 28, 2001: Queen's Scientific Breakthrough Fund
makes $300,000 investment in Online Creator, Inc.
GO
>>
March 28, 2001: Queen's Scientific Breakthrough Fund
makes $300,000 investment in Enerworks Inc.
GO
>>
February 14, 2001: New venture investment fund for Queen's
University
GO
>>
January 30, 2001: PARTEQ President wins Kingston Technology
Council's Champion Award
GO
>>
|
